FFCP PHASE2:Hg19::chr4:154265784..154265819,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p2@MND1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_MND1_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000240488, ENST00000503967, NM_001253861, NM_032117, NR_045605, uc003ink.1_5end |
EntrezGene: | MND1 |
HGNC: | 24839 |
UniProt: | Q9BWT6 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@MND1 |
---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 9.86e-47 | 235 |
disease of cellular proliferation | 1.66e-44 | 239 |
organ system cancer | 2.62e-29 | 137 |
hematologic cancer | 3.92e-28 | 51 |
immune system cancer | 3.92e-28 | 51 |
leukemia | 3.88e-23 | 39 |
cell type cancer | 4.18e-19 | 143 |
myeloid leukemia | 1.58e-17 | 31 |
carcinoma | 9.70e-16 | 106 |
lymphoma | 2.10e-07 | 10 |
Showing 1 to 10 of 11 entries